Type a ticker — we pressure-test it against live facts, filings, and sentiment.
Johnson & Johnson — Healthcare · Drug Manufacturers—General carries a Plainview business-quality score of 8.1/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.
On the fundamentals, Johnson & Johnson shows trailing revenue of $97.93B, a 68.1% gross margin, net debt of $28.28B, EPS of 8.91, valued at about 6.5x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.
Compare: JNJ vs UNH · JNJ vs LLY · JNJ vs PFE | Also: UNH, LLY, PFE, MRK, ABBV, TMO